Search results
Clasp launches with $150M and a plan for precision cancer immunotherapies
BioPharma Dive via Yahoo Finance· 3 months agoThe company claims its approach could yield more effective and safer T-cell engagers, a type of...
The company claims its approach could yield more effective and safer T-cell engagers, a type of...